Clinical Trial Update: Metabolic Effects of GH and IGF-I in Growth Hormone Deficient(GHD) and Diabetes and Impaired Glucose Tolerance(IGT) [Phase 3]

View source ↗

Summary

Phase 3 trial update on the metabolic effects of growth hormone and IGF-I in growth hormone deficiency with diabetes and impaired glucose tolerance; the study s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Growth Hormone Deficiency
• Impaired Glucose Tolerance

Drugs mentioned

• INCRELEX (Mecasermin)
• Somatropin (somatropin)

Snippet

Sponsor: Karolinska University Hospital | Conditions: Diabetes | Phase 3 | Status: COMPLETED